2019 Novel Coronavirus Disease (COVID-19)

The 2019 novel coronavirus disease (COVID-19) is a virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is thought to spread from person to person in close contact through respiratory droplets. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic.

At BioReference, our priority remains in the health and safety of our employees, and the healthcare providers, patients and communities we serve, and we are doing our part to deliver answers during these uncertain times.

COVID-19 Information

COVID-19 Testing

COVID-19 testing is imperative in helping healthcare providers identify infected and exposed patients more quickly. BioReference has been working expeditiously to develop and offer test services that will yield high quality and accurate results, including a molecular test for helping with COVID-19 diagnosis and a serology test to help indicate possible COVID-19 exposure.

MOLECULAR TEST FOR COVID-19 DIAGNOSIS: BioReference offers a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay, to ensure patients and providers have greater access to testing to promote earlier diagnosis and help limit spread of infection.

SEROLOGY TEST FOR COVID-19 EXPOSURE: BioReference offers a COVID-19 antibody immunoassay which measures SARS-CoV-2 specific antibody levels, correlating with the patient’s immune response after COVID-19 infection.

COVID-19 Response

In response to the COVID-19 global pandemic, BioReference has completed the following to help support patients, providers and government agencies:

Frequently Asked Questions

The CDC provides many resources for providers and others to help guide the evaluation and management of patients.

CLick here to to access a general list of frequently asked questions

We continue to closely monitor and respond to this rapidly evolving situation. Please continue to visit this page for the most up-to-date information or call 833-684-0508.

Healthcare providers should notify their local or state health department immediately in the event of a patient under investigation for COVID-19. Patients should call their state’s COVID-19 hotline with any state-by-state questions. Please visit the CDC website for more information here.

On Tuesday, March 10, 2020, members of the BioReference leadership team held a call to update our health plan colleagues regarding the efforts BioReference is undertaking in response to this outbreak. To receive a recording of this call, click “Request”